7Baggers

Intra-Cellular Therapies, Inc
(NASDAQ:ITCI) 

ITCI stock logo

Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases, and other disorders of the central nervous system (CNS) in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It i...

Founded: 2002
Full Time Employees: 330
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 
                                                  
      revenues
                                60,195.5 30,754 114,741 95,287 58,201.75 4,362 228,445  15,176.25  57,390 3,315 127,859.75 124,414 219,238 167,787 477,367.75 667,955 
      product sales
    199,223,000 175,159,000 161,276,000 144,843,000 131,506,000 125,810,000 110,128,000 94,731,000 87,433,000 71,870,000 55,074,000 34,755,000 25,516,026 21,606,163 19,006,780 15,578,905 12,403,754 7,368,594 1,875,889 882,516                           
      grant revenue
     216,000 112,000 23,000 593,000 363,000 664,000 575,000 436,000  505,000 241,000 154,900 601,038 1,039,781 299,424 50,516  30,747 200,963                           
      total revenues
    199,223,000 175,375,000 161,388,000 144,866,000 132,099,000 126,173,000 110,792,000 95,306,000 87,869,000 71,870,000 55,579,000 34,996,000 25,670,926 22,207,201 20,046,561 15,878,329 12,454,270 7,368,594 1,906,636 1,083,479                           
      yoy
    50.81% 39.00% 45.67% 52.00% 50.34% 75.56% 99.34% 172.33% 242.29% 223.63% 177.25% 120.40% 106.12% 201.38% 951.41% 1365.49%                               
      qoq
    13.60% 8.67% 11.41% 9.66% 4.70% 13.88% 16.25% 8.46% 22.26% 29.31% 58.82% 36.33% 15.60% 10.78% 26.25% 27.49% 69.02% 286.47% 75.97%                            
      operating expenses:
                                                  
      cost of product sales
    20,405,000 15,304,000 11,354,000 9,900,000 10,702,000 9,129,000 7,163,000 6,751,000 6,788,000 5,850,000 4,650,000 3,155,000 2,538,028 2,001,315 2,040,031 1,455,215 1,141,072 556,107 128,539 69,311                           
      selling, general and administrative
    137,729,000 132,101,000 121,574,000 113,085,000 104,720,000 105,207,000 101,014,000 98,923,000 94,631,000 88,375,000 100,316,000 75,460,000 79,678,352 70,497,885 69,851,164 52,583,639 58,347,948 52,473,573 41,445,557 34,096,366                           
      research and development
    70,286,000 66,819,000 56,183,000 42,833,000 50,774,000 41,550,000 49,794,000 38,024,000 33,862,000 33,274,000 38,536,000 29,043,000 29,459,100 27,031,825 17,296,420 15,058,168 14,298,586 10,275,368 25,204,857 16,003,326 19,065,725 21,339,792 23,728,464 24,990,856 33,605,629 35,419,016 32,439,270 30,702,998 26,929,041 18,472,372 12,478,638 21,538,958 21,179,010 23,918,232 25,300,668 23,433,620 22,865,498 28,457,631 17,762,518 18,632,427 11,641,009 4,046,335 2,709,702 2,829,299 6,129,675 4,157,742 
      total operating expenses
    228,420,000 214,224,000 189,111,000 165,818,000 166,196,000 155,886,000 157,971,000 143,698,000 135,281,000 127,499,000 143,502,000 107,658,000 111,675,480 99,531,025 89,187,615 69,097,022 73,787,606 63,305,048 66,778,953 50,169,003                           
      income from operations
    -29,197,000 -38,849,000 -27,723,000 -20,952,000 -34,097,000 -29,713,000 -47,179,000 -48,392,000 -47,412,000 -55,629,000 -87,923,000 -72,662,000 -86,004,554 -77,323,824 -69,141,054 -53,218,693 -61,333,336 -55,936,454 -64,872,317 -49,085,524 -41,768,659 -36,376,236 -39,171,114 -36,695,840 -42,622,940 -43,391,345 -39,168,257 -37,084,226 -32,708,264 -23,759,195 -18,618,513 -27,754,157 -28,032,613 -30,184,398 -31,544,027 -28,497,853 -29,372,956 -32,349,375 -21,690,925 -22,400,740 -15,297,070 -6,503,606 -4,611,584 -4,574,463 -8,032,835 -4,785,358 
      yoy
    -14.37% 30.75% -41.24% -56.70% -28.08% -46.59% -46.34% -33.40% -44.87% -28.06% 27.16% 36.53% 40.22% 38.24% 6.58% 8.42% 46.84% 53.77% 65.61% 33.76% -2.00% -16.17% 0.01% -1.05% 30.31% 82.63% 110.37% 33.62% 16.68% -21.29% -40.98% -2.61% -4.56% -6.69% 45.42% 27.22% 92.02% 397.41% 370.36% 389.69% 90.43% 35.91%     
      qoq
    -24.84% 40.13% 32.32% -38.55% 14.75% -37.02% -2.51% 2.07% -14.77% -36.73% 21.00% -15.51% 11.23% 11.83% 29.92% -13.23% 9.65% -13.77% 32.16% 17.52% 14.82% -7.14% 6.75% -13.91% -1.77% 10.78% 5.62% 13.38% 37.67% 27.61% -32.92% -0.99% -7.13% -4.31% 10.69% -2.98% -9.20% 49.14% -3.17% 46.44% 135.21% 41.03% 0.81% -43.05% 67.86%  
      operating margin %
    -14.66% -22.15% -17.18% -14.46% -25.81% -23.55% -42.58% -50.78% -53.96% -77.40% -158.19% -207.63% -335.03% -348.19% -344.90% -335.17% -492.47% -759.12% -3402.45% -4530.36% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% 
      interest income
    11,995,000 12,899,000 11,560,000 6,064,000 5,966,000 5,498,000 4,530,000 4,349,000 3,386,000 2,122,000 1,320,000 548,000 270,617 392,695 421,028 483,750 -7,826,572 752,829 1,160,059 1,678,203 -11,396,736 1,513,837 1,731,550 1,860,077 -12,407,010 1,868,431 1,793,474 1,604,148 -6,570,611 884,763 857,809 822,175 -5,065,004 763,949 709,573 656,404 540,040 188,892 179,607 113,916 99,540 88,099 80,077 36,220 18,028 5,626 
      income before benefit from income taxes
    -17,202,000 -25,950,000 -16,163,000 -14,888,000 -28,131,000 -24,215,000 -42,649,000 -44,043,000 -44,026,000 -53,507,000 -86,603,000 -72,114,000 -85,733,937 -76,931,129 -68,720,026 -52,734,943 -60,688,946 -55,183,625 -63,712,258 -47,407,321 -26,784,431.75 -34,862,399 -37,439,564 -34,835,763 -28,594,443.75 -41,522,914 -37,374,783 -35,480,078 -16,891,779.5 -22,874,432 -17,760,704 -26,931,982               
      income tax expense
    317,000 -374,000 -57,000 -359,000 -448,000 -43,000 -135,000 -10,000    5,000   23,756 5,000 10,232   3,281 400  1,600    1,600     1,600 1,898,291 -832,618             
      net income
    -16,885,000 -26,324,000 -16,220,000 -15,247,000 -28,579,000 -24,258,000 -42,784,000 -44,053,000 -44,026,000 -53,508,000 -86,603,000 -72,119,000 -85,733,937 -76,908,004 -68,743,782 -52,739,943 -60,699,178 -55,183,625 -63,712,258 -47,410,602 -40,582,851 -34,862,399 -37,441,164 -34,835,763 -40,748,036 -41,522,914 -37,376,383 -35,480,078 -30,208,712 -22,870,416 -17,760,704 -26,933,582 -27,485,039 -30,265,327 -30,834,454 -27,841,449 -28,834,516 -32,160,483 -21,511,318 -22,286,824 -15,199,130 -6,415,507 -4,533,539 -4,543,284 -8,040,810 -4,911,620 
      yoy
    -40.92% 8.52% -62.09% -65.39% -35.09% -54.66% -50.60% -38.92% -48.65% -30.43% 25.98% 36.74% 41.24% 39.37% 7.90% 11.24% 49.57% 58.29% 70.17% 36.10% -0.41% -16.04% 0.17% -1.82% 34.89% 81.56% 110.44% 31.73% 9.91% -24.43% -42.40% -3.26% -4.68% -5.89% 43.34% 24.92% 89.71% 401.29% 374.49% 390.54% 89.02% 30.62%     
      qoq
    -35.86% 62.29% 6.38% -46.65% 17.81% -43.30% -2.88% 0.06% -17.72% -38.21% 20.08% -15.88% 11.48% 11.88% 30.34% -13.11% 9.99% -13.39% 34.38% 16.82% 16.41% -6.89% 7.48% -14.51% -1.87% 11.09% 5.34% 17.45% 32.09% 28.77% -34.06% -2.01% -9.19% -1.85% 10.75% -3.44% -10.34% 49.50% -3.48% 46.63% 136.91% 41.51% -0.21% -43.50% 63.71%  
      net income margin %
    -8.48% -15.01% -10.05% -10.52% -21.63% -19.23% -38.62% -46.22% -50.10% -74.45% -155.82% -206.08% -333.97% -346.32% -342.92% -332.15% -487.38% -748.90% -3341.61% -4375.77% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% 
      net income per common share:
                                                  
      basic & diluted
    -150 -250 -160 -160 -300 -250 -450 -460 -460 -570 -920 -780 -1.06 -0.95 -0.85 -0.65 -0.75 -0.79 -0.96 -0.73 -0.74 -0.63 -0.68 -0.63 -0.75 -0.76 -0.68 -0.65 -0.56 -0.53 -0.41 -0.62 -0.63 -0.7 -0.71 -0.64 -0.66 -0.91 -0.61 -0.72 -0.52 -0.22 -0.15 -0.17   
      weighted-average number of common shares:
                                                  
      income tax benefit
            -1,500 -1,000   -1,407.75 23,125               604 4,016                 
      costs and expenses:
                                                  
      general and administrative
                        22,763,547 15,036,444 15,442,650 11,704,984 9,017,311 7,972,329 6,728,987 6,381,228 5,784,278 5,317,577 6,254,616 6,310,486 6,951,498 6,270,528 6,471,804 5,064,233 6,538,117 3,891,744 3,985,797 3,771,628 3,721,923 2,581,685 2,121,120 1,912,951 2,730,691 1,295,571 
      total costs and expenses
                        41,829,272 36,376,236 39,171,114 36,695,840 42,622,940 43,391,345 39,168,257 37,084,226 32,713,319 23,789,949 18,733,254 27,849,444 28,130,508 30,188,760 31,772,472 28,497,853 29,403,615 32,349,375 21,748,315 22,404,055 15,362,932 6,628,020 4,830,822 4,742,250 8,860,366 5,453,313 
      income tax (benefit) expense
                            400                      
      interest expense
                                    49,041 -12,260         -2,032 -5,041 -8,003 -131,888 
      net income before income tax
                                    -22,027,152.75 -29,432,709             
      income taxes
                                                  
      net income per common share:
                                                  
      basic
                                                -0.608 -0.42 
      dilutive
                                                -0.608 -0.42 
      basic & dilutive
                                                1,934,312.5 11,779,745 
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 
                                                     
        assets
                                                     
        current assets:
                                                     
        cash and cash equivalents
      306,948,000 464,312,000 693,306,000 139,819,000 147,767,000 99,402,000 142,258,000 75,727,000 148,615,000 135,358,000 77,235,000 129,295,000 92,364,990 106,125,959 121,030,152 129,979,888 60,045,933 300,988,981 129,290,445 179,593,032 107,636,849 102,162,982 91,763,368 64,091,080 54,947,502 69,776,956 69,767,045 74,421,386 37,790,114 52,340,519 29,590,446 23,598,325 48,642,225 200,388,020 51,972,773 37,240,565 47,159,303 332,828,289 71,418,286 100,802,133 61,325,044 68,915,333 91,140,138 143,618,247 35,150,924 44,072,012  
        investment securities, available-for-sale
      694,118,000 542,250,000 329,601,000 335,804,000 350,174,000 393,619,000 370,596,000 462,981,000 443,290,000 493,383,000 600,594,000 642,553,000 319,968,348 371,157,974 433,727,230 481,984,786 597,402,126 420,958,509 278,468,502 269,360,926 116,373,335 153,270,596 193,536,800 248,731,291 292,583,046 306,211,066 333,997,440 362,584,126 426,540,921 275,781,285 313,037,669 344,183,051 335,458,459 337,405,780 390,717,316 418,827,867 428,041,021 177,903,693 132,570,900 134,424,335 68,320,672 67,066,729 49,355,284     
        restricted cash
      1,750,000 1,750,000 1,750,000 1,750,000 1,750,000 1,750,000 1,750,000 1,750,000 1,750,000 1,750,000 1,400,000 1,400,000 1,400,000 1,400,000 1,400,000 1,400,000 1,400,000 1,400,000 1,400,000 1,400,000                            
        accounts receivable
      166,500,000 145,608,000 145,714,000 131,157,000 114,018,000 102,670,000 95,964,000 81,545,000 75,189,000 61,538,000 46,976,000 32,832,000 20,155,994 16,934,352    7,480,604 2,353,255 1,351,013          6,309 61,935 68,200 94,339 1,309 98,240  30,660  9,118 3,315 51,603 124,414 219,238 167,787 336,318 251,291  
        inventory
      26,283,000 23,539,000 20,082,000 15,949,000 11,647,000 42,986,000 41,895,000 28,341,000 23,920,000 23,597,000 25,022,000 7,893,000 7,948,126 8,166,935 7,768,848 7,579,393 7,056,385 2,947,138 2,335,042 1,391,124                            
        prepaid expenses and other current assets
      111,765,000 94,272,000 73,798,000 66,048,000 42,443,000 61,998,000 45,610,000 55,750,000 45,193,000 44,130,000 37,979,000 34,369,000 25,443,372 29,457,445 22,189,200 14,494,384 14,235,455 11,090,774 4,726,134 7,876,405 6,313,785 4,023,348 3,041,730 8,305,259 7,908,133 7,265,428 5,896,583 6,148,067 4,884,293 5,307,357 6,144,819 3,761,282 4,005,093 4,023,405 4,020,092 6,790,104 8,025,147 1,532,908 8,612,651 1,267,369 1,288,953 1,374,378 493,356 585,104 762,243 806,288  
        total current assets
      1,307,364,000 1,271,731,000 1,264,251,000 690,527,000 667,799,000 702,425,000 698,073,000 706,094,000 737,957,000 759,756,000 789,206,000 848,342,000 467,280,830 533,242,665 601,303,244 649,100,443 690,904,482 744,866,006 418,573,378 460,972,500 230,323,969 259,456,926 288,341,898 321,127,630 355,438,681 383,253,450 409,661,068 443,153,579 469,215,328 333,435,470 348,834,869 371,610,858 388,200,116 541,818,514 446,808,421 462,858,536 483,256,131 512,264,890 212,610,955 236,497,152 130,986,272 137,480,854 141,208,016 146,371,138 38,249,485 47,129,591 49 
        property and equipment
      1,468,000 2,005,000 1,445,000 1,522,000 1,654,000 1,789,000 1,656,000 1,779,000 1,913,000 2,084,000 2,137,000 2,185,000 1,790,724 1,936,308 1,761,001 1,871,338 1,998,346 2,049,552 2,000,687 2,132,987 2,259,740 2,174,993 2,082,933 1,125,606 1,159,766 1,196,480 1,275,387 1,349,765 1,137,171 679,606 628,901 605,683 627,614 677,703 718,659 731,429 775,522 785,544 722,131 559,709 54,553 57,440 63,850 65,075 68,272 75,700  
        right of use assets
      13,428,000 14,011,000 14,507,000 12,481,000 12,928,000 13,364,000 13,787,000 14,199,000 14,824,000 20,073,000 20,477,000 17,967,000 20,764,458 21,710,677 22,546,333 23,430,703 24,324,762 24,292,167 20,270,675 18,051,146 18,252,074 18,540,418 18,822,482 20,104,280                        
        inventory, non-current
      38,890,000 30,479,000 32,562,000 34,818,000 38,621,000                                           
        other assets
      5,762,000 6,219,000 7,739,000 7,688,000 7,293,000 86,000 86,000 86,000 86,000 86,000 86,000 86,000 86,084 86,084 86,084 86,084 86,084 86,084 86,084 86,084 86,084 86,084 86,083 86,083 78,833 78,833 78,833 77,293 75,765 75,765 75,765 75,765 75,765 75,765 75,765 71,875 71,875 71,875 70,944 70,944 70,944 70,944 70,944 200,447 131,555 130,755  
        total assets
      1,366,912,000 1,324,445,000 1,320,504,000 747,036,000 728,295,000 717,664,000 713,602,000 722,158,000 754,780,000 781,999,000 811,906,000 868,580,000 489,922,096 556,975,734 625,696,662 674,488,568 717,313,674 771,293,809 440,930,824 481,242,717 251,186,476 280,523,030 309,862,614 342,972,817 357,206,498 385,587,198 412,073,723 445,639,072 471,486,699 334,190,841 349,539,535 372,292,306 388,903,495 542,571,982 447,602,845 463,661,840 484,103,528 513,122,309 213,404,030 237,127,805 131,111,769 137,609,238 141,342,810 146,636,660 38,449,312 47,336,046 49 
        liabilities and stockholders’ equity
                                                     
        current liabilities:
                                                     
        accounts payable
      26,074,000 10,338,000 17,548,000 11,532,000 11,452,000 10,613,000 7,733,000 8,441,000 10,395,000 14,219,000 10,749,000 11,649,000 8,691,220 12,030,614 15,940,756 8,720,957 5,501,825 8,569,148 5,472,987 10,994,082 7,425,024 6,230,923 5,632,783 8,574,433 13,961,060 10,453,186 5,378,870 10,038,850 6,173,539 4,407,655 1,775,252 7,157,746 3,754,647 5,417,451 3,889,566 1,959,272 1,632,905 705,043 4,911,065 4,574,351 2,052,765 503,882 415,791 2,142,779 3.395 4,027,097  
        accrued and other current liabilities
      65,215,000 51,540,000 39,713,000 33,249,000 27,944,000 27,829,000 27,456,000 21,067,000 19,657,000 14,850,000 17,274,000 12,258,000 11,072,996 16,928,669 14,054,009 13,491,620 10,902,117 12,186,380 19,383,111 10,667,765 16,138,909 17,323,632 18,801,485 18,700,638 20,044,866 14,168,130 10,462,217 7,355,955 6,424,221 4,151,120 2,781,198 7,039,115 5,329,293 7,520,073 12,981,891 5,241,839 3,423,464 8,575,333 3,340,399 9,029,493 7,529,241 2,143,756 1,434,875 940,594 2,611,091 2,571,126  
        accrued customer programs
      75,408,000 70,536,000 77,971,000 69,972,000 53,173,000 35,618,000 31,710,000 29,892,000 25,621,000 19,946,000 16,483,000 10,888,000 5,963,610                                   
        accrued employee benefits
      34,774,000 29,496,000 22,372,000 16,409,000 27,364,000 25,448,000 21,623,000 16,656,000 22,996,000 21,150,000 18,385,000 16,643,000 20,896,860 14,854,226 14,832,115 11,915,893 14,907,479 12,005,931 11,412,697 6,203,283 9,472,651 7,531,659 5,829,242 3,351,208 2,293,259 4,507,580 3,094,280 2,257,963 1,611,846 3,316,378 2,406,269 2,121,795 1,448,394 2,752,381 2,509,611 1,745,561 1,207,143 1,106,620 1,066,629 988,897 975,058 929,963 888,588 828,262 827,879 759,757  
        operating lease liabilities
      4,233,000 4,203,000 4,171,000 3,639,000 3,612,000 3,584,000 3,558,000 3,531,000 4,567,000                                       
        total current liabilities
      205,704,000 166,113,000 161,775,000 134,801,000 123,545,000 103,092,000 92,080,000 79,587,000 83,236,000 77,410,000 70,634,000 59,074,000 53,356,478 49,895,563 50,421,937 39,701,710 36,853,223 38,028,717 40,242,715 31,076,364 36,224,019 33,373,099 32,526,487 33,499,301 36,299,185 29,128,896 18,935,367 19,652,768 14,209,606 11,875,153 6,962,719 16,318,656 10,532,334 140,689,905 19,381,068 8,946,672 6,263,512 10,386,996 9,318,093 14,592,741 10,557,064 3,577,601 2,739,254 3,911,635 6,834,037 7,774,662 33,032 
        operating lease liabilities, non-current
      12,748,000 13,506,000 14,117,000 12,737,000 13,326,000 13,891,000 14,432,000 14,961,000                                        
        total liabilities
      218,452,000 179,619,000 175,892,000 147,538,000 136,871,000 116,983,000 106,512,000 94,548,000 98,710,000 96,577,000 89,709,000 75,830,000 72,031,421 70,219,481 72,110,788 62,338,810 60,453,570 61,898,274 61,400,956 50,794,387 56,179,205 53,642,745 53,094,252 54,358,390 39,491,617 31,961,802 21,686,281 22,450,117 17,049,738 14,750,765 9,873,811 19,265,229 13,400,956 143,253,714 21,640,064 10,917,419 7,860,617 11,268,139 9,838,721 14,752,853        
        stockholders’ equity:
                                                     
        common stock
      11,000 11,000 11,000 10,000 10,000 10,000 10,000 10,000 9,000 9,000 9,000 9,000 8,189 8,138 8,132 8,113 8,046 8,014 6,678 6,620 5,551 5,525 5,519 5,513 5,490 5,471 5,470 5,469 5,460 4,342 4,342 4,342 4,329 4,327 4,325 4,323 4,316 4,301 3,504 3,497 2,950 2,940 2,934 2,922 2,216 2,213  
        additional paid-in capital
      2,840,094,000 2,818,137,000 2,793,896,000 2,232,325,000 2,208,470,000 2,190,587,000 2,173,671,000 2,151,837,000 2,137,737,000 2,124,369,000 2,106,942,000 2,089,418,000 1,639,475,837 1,622,149,674 1,611,989,381 1,601,739,075 1,593,475,506 1,585,023,637 1,199,576,320 1,188,095,880 904,971,772 896,191,230 891,183,518 885,888,318 880,753,339 876,094,265 871,516,637 867,152,094 862,479,505 696,695,317 694,146,861 689,723,391 685,290,815 681,475,390 677,623,643 673,679,915 669,878,103 666,083,825 335,668,581 332,948,140 208,912,345 207,152,913 205,289,691 204,829,884 89,177,556 89,082,858 9,500 
        accumulated deficit
      -1,691,836,000 -1,674,951,000 -1,648,627,000 -1,632,407,000 -1,617,160,000 -1,588,581,000 -1,564,323,000 -1,521,539,000 -1,477,486,000 -1,433,460,000 -1,379,952,000 -1,293,349,000 -1,221,229,698 -1,135,495,761 -1,058,587,757 -989,843,975 -937,104,032 -876,404,854 -821,221,229 -757,508,971 -710,098,369 -669,515,518 -634,653,119 -597,211,954 -562,376,191 -521,628,155 -480,105,241 -442,728,858 -407,248,780 -377,040,068 -354,169,652 -336,408,948 -309,475,366 -281,990,327 -251,725,000 -220,890,547 -193,049,098 -164,214,582 -132,054,099 -110,542,781 -88,255,957 -73,056,827 -66,641,320 -62,107,781 -57,564,497 -49,523,687  
        accumulated comprehensive income
      191,000 1,629,000 -668,000 -430,000 104,000        -363,653 94,202 176,118 246,545 480,584 768,738 1,168,099                             
        total stockholders’ equity
      1,148,460,000 1,144,826,000 1,144,612,000 599,498,000 591,424,000 600,681,000 607,090,000 627,610,000 656,070,000 685,422,000 722,197,000 792,750,000 417,890,675 486,756,253 553,585,874 612,149,758 656,860,104 709,395,535 379,529,868 430,448,330 195,007,271 226,880,285 256,768,362 288,614,427 317,714,881 353,625,396 390,387,442 423,188,955 454,436,961 319,440,076 339,665,724 353,027,077 375,502,539 399,318,268 425,962,781 452,744,421 476,242,911 501,854,170 203,565,309 222,374,952 120,554,705 134,031,637 138,603,556 142,725,025 31,615,275 39,561,384  
        total liabilities and stockholders’ equity
      1,366,912,000 1,324,445,000 1,320,504,000 747,036,000 728,295,000 717,664,000 713,602,000 722,158,000 754,780,000 781,999,000 811,906,000 868,580,000 489,922,096 556,975,734 625,696,662 674,488,568 717,313,674 771,293,809 440,930,824 481,242,717 251,186,476 280,523,030 309,862,614 342,972,817 357,206,498 385,587,198 412,073,723 445,639,072 471,486,699 334,190,841 349,539,535 372,292,306 388,903,495 542,571,982 447,602,845 463,661,840 484,103,528 513,122,309 213,404,030 237,127,805 131,111,769 137,609,238 141,342,810 146,636,660 38,449,312 47,336,046  
        accumulated comprehensive loss
           -1,335,000 -2,268,000 -2,698,000 -4,190,000 -5,496,000 -4,802,000 -3,328,000            -67,450 -667,757 -846,185 -1,029,424 -1,239,750 -799,224 -219,515 -315,827 -291,708 -317,239 -171,122  -49,270 -590,410 -19,374 -52,677 -33,904 -104,633       
        operating lease liabilities, non-current,
              15,474,000                                       
        lease liabilities, short-term
               7,245,000 7,743,000 7,636,000 6,731,792 6,082,054 5,595,057 5,573,240 5,541,802 5,267,258 3,973,920 3,211,234 3,187,435 2,286,885 2,262,977 2,873,022                        
        lease liabilities
               19,167,000 19,075,000 16,756,000 18,674,943 20,323,918 21,688,851 22,637,100 23,600,347 23,869,557 21,158,241 19,718,023 19,955,186 20,269,646 20,567,765                         
        accounts receivable, net of 120,000 allowance at june 30, 2021 and december 31, 2020
                    15,187,814                                 
        accounts receivable, net of 120,000 allowance at march 31, 2021 and december 31, 2020
                     13,661,992                                
        accounts receivables
                      10,764,583                               
        deferred tax asset
                          264,609 264,609 529,218                         
        accumulated comprehensive gain
                         -145,199               59,813             
        deferred rent
                                                     
        accumulated comprehensive gain/
                          128,317 199,048 232,444                         
        long term deferred tax asset
                             529,218 529,218 1,058,435 1,058,435 1,058,435 1,058,435                   
        long-term deferred rent
                              3,192,432 2,832,906 2,750,914 2,797,349 2,840,132    2,868,622    1,597,105 881,143 520,628         
        long-term lease liabilities
                             20,859,089                        
        long-term liabilities
                                   2,875,612 2,911,092 2,946,573  2,563,809 2,258,996 1,970,747    160,112        
        borrowing under secured line of credit
                                       125,000,000              
        accumulated other comprehensive loss
                                               -67,389 -47,749     
        certificates of deposit
                                                 2,000,000 2,000,000 2,000,000  
        deferred revenue—short-term
                                                     
        liabilities, redeemable convertible preferred stock, and stockholders’ deficit
                                                     
        deferred revenue
                                                   416,682  
        stockholders’ equity
                                                     
        cash
                                                    49 
        liabilities and stockholder's deficiency
                                                     
        accounts payable and accrued expenses
                                                    23,732 
        loan payable - related party
                                                    3,400 
        note payable - related party
                                                    5,900 
        commitments and contingencies
                                                     
        stockholder's deficiency:
                                                     
        preferred stock, .0001 par value...
                                                     
        common stock, .0001 par value...
                                                    500 
        accumulated deficit during the development stage
                                                    -42,983 
        total stockholder's deficiency
                                                    -32,983 
        total liabilities and stockholder's equity
                                                    49 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-06-30 
                                                      
          cash flows used in operating activities
                                                      
          net income
        -16,885,000 -26,324,000 -16,220,000 -15,247,000 -28,579,000 -24,258,000 -42,784,000 -44,053,000 -44,026,000 -53,508,000 -86,603,000 -72,119,000 -85,733,937 -76,908,004 -68,743,782 -52,739,943 -60,699,178 -55,183,625 -63,712,258 -47,410,602 -40,582,851 -34,862,399 -37,441,165 -34,835,763 -40,748,036 -41,522,914 -37,376,383 -35,480,078 -30,208,712 -22,870,416 -17,760,704 -26,933,582 -27,485,039 -30,265,327 -30,834,453 -27,841,449 -28,834,516 -32,160,483 -21,511,318 -22,286,824 -15,199,130 -6,415,507 -4,533,539 -4,543,284 -8,040,810  
          adjustments to reconcile net income to net cash from operating activities:
                                                      
          depreciation
        109,000 138,000 129,000 132,000 136,000 135,000 123,000 134,000 143,000 170,000 172,000 171,000 146,826 133,945 125,581 127,008 125,972 121,044 132,300 148,802  129,052 105,056 101,353  94,930 95,778 82,498  53,461 51,372 50,429  50,070 48,747 47,967  45,474 31,880 15,240  6,409 6,430 6,317 7,428  
          share-based compensation
        16,333,000 17,489,000 16,370,000 13,843,000 14,856,000 14,311,000 13,226,000 10,439,000 11,159,000 11,751,000 11,998,000 8,105,000 9,377,619 9,530,269 8,616,705 6,778,436 4,763,047 6,900,719 6,947,134 5,504,297 5,939,279 4,806,768 4,987,424 5,055,217                       
          stock issued for services
        18,000 18,000 23,000 23,000 23,000 24,000 23,000 22,000 22,000 22,000 22,000 24,000 34,335 38,734 51,923 53,542 53,520 53,528 53,522 53,533 48,514 48,571 48,571 48,549                       
          amortization of premiums and accretion of discounts on investment securities
        -2,986,000 -1,847,000 -1,853,000 -2,343,000 -2,539,000 -2,191,000 -1,933,000 -1,737,000                                       
          changes in operating assets and liabilities:
                                                      
          accounts receivable
        -20,892,000 106,000 -14,557,000 -17,139,000 -11,348,000 -6,706,000 -14,419,000 -6,356,000 -13,651,000 -14,562,000 -14,144,000 -12,676,000 -3,221,642 -1,746,538 -1,525,822 -2,897,409 -3,283,979 -5,127,349 -1,002,242 -1,351,013         6,309 55,626 6,265 26,139 -93,030 96,931 -98,240 30,660 -30,660 9,118 -5,803 48,288 72,811 94,824 -51,451 168,531 -85,027  
          inventory
        -11,155,000 -1,374,000 -1,877,000 -499,000 -7,282,000 -1,091,000 -13,554,000 -4,421,000 -323,000 1,425,000 -17,129,000 55,000 218,809 -398,087 -189,455 -523,008 -4,109,247 -612,096 -943,918 -1,391,124                           
          prepaid expenses and other assets
        -17,036,000 -18,954,000 -7,801,000 -24,000,000 12,348,000 -16,388,000 10,140,000 -10,557,000 -1,063,000 -6,151,000 -3,608,000 -8,927,000 4,014,073 -7,268,245 -7,694,816 -258,929 -3,144,681 -6,364,640 3,150,271 -1,562,620 -2,555,046 -717,010 5,263,529 -526,089 -642,705 -1,368,845 249,944 -1,265,302 423,064 837,462 -2,383,537 243,811 18,312 -3,313 2,766,122 1,235,043 -6,492,239 7,078,812 -7,345,282 21,584 85,425 -881,022 221,251 108,247 43,245  
          accounts payable
        15,736,000 -7,210,000 6,016,000 80,000 839,000 2,880,000 -708,000 -1,954,000 -3,824,000 3,470,000 -900,000 2,958,000 -3,339,394 -3,910,142 7,219,799 3,219,132 -3,067,323 3,096,161 -5,521,095 3,569,058 1,194,101 598,140 -2,941,650 -5,386,627 3,507,874 5,074,316 -4,659,980 3,865,311 1,765,884 2,632,403 -5,382,494 3,403,099 -1,662,804 1,527,885 1,930,294 326,367 927,862 -4,206,022 336,714 2,521,586 1,548,883 88,091 -1,726,988 -1,252,288 -632,030  
          accrued and other current liabilities
        13,675,000 11,827,000 6,464,000 5,305,000 115,000 373,000 6,389,000 1,410,000 4,807,000                                      
          accrued customer programs
        4,872,000 -7,435,000 7,999,000 16,799,000 17,555,000 3,908,000 1,818,000 4,271,000 5,675,000 3,463,000 10,514,076 4,924                                   
          accrued employee benefits
        5,278,000 7,124,000 5,963,000 -10,955,000 1,916,000 3,825,000 4,967,000 -6,340,000 1,846,000                                      
          lease liabilities
                -1,122,000 -2,000 -86,000 1,784,000 -53,018 -42,280 -42,062 -37,750 -27,261 -16,838 -16,625 -12,436                           
          net cash from operating activities
        -13,078,000 -26,525,000 542,000 -34,116,000 -2,061,000 -25,270,000 -36,802,000 -60,066,000 -39,193,000 -53,351,000 -94,793,000 -82,849,000 -73,184,535 -79,266,764 -59,325,234 -47,766,952 -68,242,719 -63,579,111 -47,024,797 -51,226,218 -35,055,916 -29,989,290 -27,308,710 -35,629,325 -29,161,536 -28,409,537 -33,614,041 -26,983,999 -24,792,734 -14,412,227 -24,888,290 -16,398,561 -28,450,347 -29,657,041 -13,499,416 -19,650,423 -35,055,633 -20,510,560 -31,004,682 -15,709,090 -6,206,335 -4,420,502 -5,197,476 -6,982,837 -8,627,808 -9,921 
          capital expenditures
        427,000 -696,000 -1,000  28,000 -117,000 -123,000 -566,000 -1,242 -309,252 -74,766 -169,909 -22,049 650,293 -221,112 -1,062,383 -67,193 -58,753 -16,023 -21,400 -295,092 -516,175 -104,166 -74,590 -28,498 -9,114 -35,977 -3,874 -108,887 -194,302 -520,396 -3,438 -5,205 -3,120 
          free cash flows
        -12,651,000 -27,221,000 542,000 -34,116,000 -2,062,000 -25,270,000 -36,802,000  -39,165,000 -53,468,000 -94,916,000 -83,415,000 -73,185,777 -79,576,016 -59,325,234 -47,766,952 -68,317,485 -63,749,020 -47,024,797 -51,248,267 -34,405,623 -30,210,402 -28,371,093 -35,696,518 -29,220,289 -28,425,560 -33,635,441 -27,279,091 -25,308,909 -14,516,393 -24,962,880 -16,427,059 -28,450,347 -29,666,155 -13,535,393 -19,654,297 -35,055,633 -20,619,447 -31,198,984 -16,229,486 -6,209,773 -4,420,501 -5,202,681 -6,985,957 -8,627,808 -9,921 
          cash flows from investing activities
                                                      
          purchases of investments
        -257,602,000 -312,507,000 -88,524,000 -81,046,000 -104,464,000 -136,394,000 -65,954,000 -108,457,000 -115,502,000 -90,925,000 273,931,000 -826,713,000 -69,380,879 -35,295,188 -85,750,937 -34,147,683 -267,105,008 -203,924,385 -74,133,521 -210,466,633 -22,387,415 -32,555,011 -11,450,191 -14,327,684 -30,042,076 -57,457,564 -91,786,767 -91,870,300 -246,252,094 -68,640,217 -104,089,622 -101,944,891 -75,658,859 -137,869,225 -149,584,769 -32,644,315 -283,161,975 -137,475,341 -22,528,030 -71,142,903 -11,328,911 -19,828,139     
          maturities of investments
        107,283,000 104,000,000 96,343,000 97,225,000 151,887,000 116,495,000 160,702,000 91,995,000 165,737,000 197,212,000 -236,579,000 505,244,000 120,891,427 99,375,715 134,559,982 150,416,932 90,844,111 60,877,534 66,375,890 57,503,736 59,474,130 73,012,648 67,234,361 59,136,544 44,247,047 85,737,637 120,761,737 155,442,867 94,883,966 105,906,683 135,038,024 93,103,865 77,335,984 190,848,353 177,668,019 42,216,191 32,261,264 92,000,386 24,169,154 4,958,644 9,884,518 1,994,790    
          purchases of property and equipment
        427,000 -696,000   -1,000    28,000 -117,000 -123,000 -566,000 -1,242 -309,252   -74,766 -169,909 -22,049 650,293 -221,112 -1,062,383 -67,193 -58,753 -16,023 -21,400 -295,092 -516,175 -104,166 -74,590 -28,498  -9,114 -35,977 -3,874  -108,887 -194,302 -520,396       
          net cash from investing activities
        -149,892,000 -209,203,000 7,766,000 16,179,000 47,422,000 -20,167,000 94,748,000 -16,462,000 50,263,000 106,170,000 37,229,000 -322,035,000 51,509,306 63,771,275   -176,335,663 -143,216,760 -7,757,631 -152,984,946 37,737,008 40,236,525 54,721,787 44,741,667 14,146,218 28,264,050 28,953,570 63,277,475 -151,884,303 37,162,300 30,873,812 -8,869,524 1,677,126 52,970,014 28,047,273 9,568,002 -250,937,721 -45,583,842 1,446,822 -66,704,655 -1,447,831 -17,833,348 -47,449,991 -3,120  
          cash flows from financing activities
                                                      
          proceeds of public offerings
                        375,843,802                             
          proceeds from exercise of stock options
        5,606,000 6,734,000 2,093,000 9,989,000 3,004,000 2,581,000 8,585,000 3,640,000 2,194,000 5,654,000 5,504,000 8,089,000 7,914,260 591,296 1,581,697 1,431,658 3,635,334   589,161  152,379 259,211 31,236                       
          net cash from financing activities
        5,606,000 6,734,000 545,179,000 9,989,000 3,004,000 2,581,000 8,585,000 3,640,000 2,187,000 5,654,000 5,504,000 441,814,000 7,914,260 591,296 1,581,697 1,431,658 3,635,334 378,494,407 4,479,841 277,567,347 2,792,775 152,379 259,211 31,236 185,864 155,398 6,130 337,796 162,126,632 6,599 224,185 -124,972,574 125,102,274 184,351 163,683 324,368 327,504,405 174,013 121,890,834 63,877 29,045 169,358 115,453,280 -293,280 5,900 
          net increase in cash, cash equivalents, and restricted cash
        -157,364,000 -228,994,000 553,487,000 -7,948,000 48,365,000   -72,888,000 13,257,000 58,473,000 -52,060,000 36,930,000 -13,760,969 -14,904,193 -8,949,736 69,933,955 -240,943,048 171,698,536 -50,302,587 73,356,183                           
          cash, cash equivalents, and restricted cash at beginning of period
        149,517,000 150,365,000 93,765,000 61,445,933 107,636,849                           
          cash, cash equivalents, and restricted cash at end of period
        -157,364,000 -228,994,000 553,487,000 141,569,000 48,365,000 -42,856,000 66,531,000 77,477,000 13,257,000 58,473,000 -52,060,000 130,695,000 -13,760,969 -14,904,193 -8,949,736 131,379,888 -240,943,048 171,698,536 -50,302,587 180,993,032                           
          cash paid for taxes
        460,000                                     205,000 1,600 4,441 12,691 23,966 3,900 18,000  
          non-cash investing and financing activities
                                                      
          right of use assets under operating leases
                   8,647,089      97,234                          
          the following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows:
                                                      
          cash and cash equivalents
                       129,979,888                               
          restricted cash
                       1,400,000                               
          total cash, cash equivalents and restricted cash
                       131,379,888                               
          operating lease liabilities
         -83,000 -114,000 -115,000  -92,000 -90,000 -924,000                                       
          proceeds from sale of common stock
                                                     
          supplemental cash flow information
                                                      
          proceeds of public offering
                 433,725,000        276,978,186                           
          net decrease in cash, cash equivalents, and restricted cash
                                                      
          long term deferred tax asset
                        264,609                           
          amortization of premiums and discounts on investment securities
                 230,000 3,132,000 -4,079,000 -778,777 -1,593,187 -621,916 -1,085,948 -470,874 157,483 -36,647 -298,210  -224,829 -289,785 -356,798    -56,298                   
          non-cash investing and financing activities right of use assets under operating leases
                               219,703                       
          accrued liabilities and other
                  6,758,000 -3,069,000 6,150,571 2,896,771 3,478,611 -402,083 1,617,285 -6,603,498 13,924,761 -8,740,512  232,417 2,959,310 270,833                       
          right of use assets under operating vehicle fleet leases
                        1,166,976 4,929,098                             
          right of use assets under operating real estate leases
                                                      
          net cash from (used) in investing activities
                       116,269,249                               
          non-cash investing and financing activitiesright of use assets under operating leases
                       9,179,216                               
          deferred rent
                                323,203 -35,480 -35,481 15,342 -24,845 -24,845 -24,846 93,323 304,813 304,813 288,249 373,642 715,962 360,515 360,516 160,112       
          proceeds from stock warrant
                                                      
          proceeds from exercise of stock options and issuances of restricted stock
                                                      
          operating activities
                                                      
          depreciation expense
                                                      
          amortization of premiums and discounts on investment activities
                                                      
          accrued liabilities and employee benefits
                                                      
          investing activities
                                                      
          financing activities
                                                      
          exercise of stock options
                                                      
          net increase in cash and cash equivalents
                            5,473,867 10,399,614 27,672,288 9,143,578 -14,829,454 9,911 -4,654,341 36,631,272 -14,550,405 22,750,073   -151,745,795 148,415,247 14,732,208 -9,918,738 -285,668,986 261,410,003 -29,383,847 39,477,089 -7,590,289 -22,224,805 -52,478,109 108,467,323 -8,921,088  
          cash and cash equivalents at beginning of period
                            54,947,502 37,790,114 48,642,225 47,159,303 61,325,044 35,150,924   
          cash and cash equivalents at end of period
                            5,473,867 10,399,614 27,672,288 64,091,080 -14,829,454 9,911 -4,654,341 74,421,386 -14,550,405 22,750,073 5,992,121 23,598,325 -151,745,795 148,415,247 14,732,208 37,240,565 -285,668,986 261,410,003 -29,383,847 100,802,133 -7,590,289 -22,224,805 -52,478,109 143,618,247   
          proceeds from exercise of warrants
                                                      
          proceeds from line of credit
                                                      
          repayment of line of credit
                                                      
          proceeds from stock option exercises
                                  6,130 337,796 54,376 6,599 224,185 27,426 102,274 184,351 163,683 335,538 57,030 159,442 101,036 63,877 29,045   16,111  
          cash paid for interest
                                                2,032 5,041 8,003  
          share-based compensation expense
                                 4,373,688 4,310,705 4,287,103 3,610,948 2,500,753 4,369,141 4,160,678 3,725,288 3,686,746 3,696,724 3,592,461 3,424,310 2,865,990 2,500,779 2,099,826 1,651,018 1,702,645 290,461 199,754 108,943  
          issuance of common stock for services
                                 48,543 47,709 47,699  47,703 47,730 47,726  62,729 62,655 45,675  45,646 45,656 45,682       
          net accretion of discounts and amortization of premiums of available-for-sale securities
                                 -310,460                     
          accrued liabilities
                                 5,236,685 3,931,625 1,519,726  2,269,396 -3,984,078 2,367,851  -5,219,048 8,504,102 2,356,793  5,274,925 -5,611,362 1,514,091  750,256 554,607 -1,670,114   
          proceeds from warrants
                                                      
          cash flows from operating activities
                                                      
          issuance of stock for services
                                                      
          amortization of premiums on investment activities
                                                      
          payment of costs of public offerings
                                            -11,170          
          amortization of premiums on investment securities
                                     86,230 172,861 141,965  101,473 136,384 182,418  175,465 193,538 151,325       
          proceeds from secured line of credit
                                                      
          net decrease in cash and cash equivalents
                                       -25,043,900               
          purchase of property and equipment
                                                -3,438 -5,205 -3,120  
          proceeds from stock subscription
                                                     
          gross proceeds of public offering
                                              122,083,012  116,191,285   
          payment of costs of public offering
                                              14,571 -293,214  -10,533 -738,005   
          proceeds from stock subscriptions
                                                     
          deferred revenue
                                                    -416,682  
          proceeds from issuance of convertible promissory notes
                                                      
          gross proceeds of public offerings
                                                      
          gross proceeds of public and private offerings
                                                      
          payment of costs of public and private offerings
                                                      
          unrealized loss on investment securities
                                                      
          gross proceeds of private placement
                                                      
          payment of costs of private placement
                                                      
          cash and cash equivalents at beginning of year
                                                      
          cash and cash equivalents at end of year
                                                      
          accrued and other current liabilities and employee benefits
                                                      
          cash flows from operating activities:
                                                      
          net
                                                     -10,883 
          adjustment to reconcile net income to net cash from operating activities:
                                                      
          professional fees paid by related party on behalf of the company
                                                     3,400 
          increase in accounts payable and accrued expenses
                                                     -2,438 
          cash flows from financing activities:
                                                      
          increase in note payable - related party
                                                     5,900 
          proceeds from issuance of common stock
                                                      
          net increase in cash
                                                     -4,021 
          cash, beginning of period
                                                     4,070 
          cash, end of period
                                                     49 
          schedule of non-cash financing activities:
                                                      
          note 1 -
                                                      
          net cash (used in) operating activities
                                                      
          net cash (used in) investing activities